What this page helps you sort
Readers land here when something has changed: stock vanished, coverage changed, a provider or program stopped offering the same option, a refill stalled, side effects became hard to manage, or progress flattened. Switching is not one generic process. Different drug pairs use different timing, dose logic, restart rules, and refill logistics. A stalled refill may be administrative rather than clinical: a refill request or check-in, updated health information, clinician review, pharmacy or order processing, labs, shipping, renewal timing, payment checks, or whether the same price still applies can all affect the next fill. The safest pattern is to go straight to the guide that matches your exact situation, then confirm the plan with the prescribing clinician.
Use the exact drug-to-drug guide instead of a generic switching chart.
Do not assume one GLP-1 drug can be swapped for another at the same dose. With Zepbound to Wegovy, the standard of care is to wait 7 days from the last injection because taking one shot on Monday and the next on Tuesday risks stacking when peak concentrations overlap. With Rybelsus to Ozempic, the logic is the opposite: many clinicians use a 24-hour transition so blood levels do not fall, hunger noise does not return, and side effects are not made worse by a stop-start gap. Saxenda to Mounjaro introduces a different problem again, because the stronger dual-receptor effect can mean more nausea, vomiting, and dehydration if the transition is rushed. Use the drug-specific guide, not a generic chart.
Open a switching guideA lower restart dose after a switch is not usually a step backward.
When readers switch from one GLP-1 to another, the most frustrating part is often the forced reset. Going from a higher semaglutide dose to a low starting tirzepatide dose, or from daily Saxenda to 2.5 mg Mounjaro, can feel like losing ground. Clinically, it is the opposite. The restart protects against overlapping side effects, lets the new receptor profile declare itself, and gives the body time to adapt to a different molecule. Use this guide when the switch involves Ozempic to Mounjaro or Saxenda to Mounjaro and the real question is why the smaller number is still the safer place to restart.
Read the Ozempic-to-Mounjaro guideA refill problem is not always a dose problem.
Before you assume the treatment plan changed, check what the account page or support team lets you change: refill request or check-in, next refill date, shipment timing, renewal timing, cancellation window, and payment status.
Check refill optionsA new provider may need records before refill continuity is clear.
Switching care teams can change the refill timeline even when the medication itself is not changing. Collect the current prescription context, dose history, recent labs if they are used for refill decisions, prior authorization notes, and pharmacy or fulfillment details before you assume a new provider can renew without a fresh intake.
Check renewal rulesMilligrams do not translate cleanly across delivery methods or molecules.
A dose that looks dramatically smaller on paper is not automatically weaker. Oral semaglutide has different bioavailability than an injection, and tirzepatide is not just more semaglutide with a different brand name. That is why 14 mg of Rybelsus can transition to 0.5 mg of Ozempic, and why a direct milligram match across Saxenda, Ozempic, Wegovy, Mounjaro, and Zepbound is not safe clinical logic. Use this guide when the numbers are causing the confusion and you need the delivery method, receptor differences, and washout timing explained clearly in plain language.
Read the Rybelsus-to-Ozempic guide
